Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.100
+0.290 (7.61%)
At close: Feb 6, 2026, 4:00 PM EST
4.250
+0.150 (3.66%)
After-hours: Feb 6, 2026, 7:58 PM EST
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$1,364,029
Market Cap
366.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 34 | -8 | -19.05% |
| Sep 30, 2024 | 42 | 2 | 5.00% |
| Sep 30, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2022 | 38 | 13 | 52.00% |
| Sep 30, 2021 | 25 | 5 | 25.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Rocket Pharmaceuticals | 299 |
| Allogene Therapeutics | 229 |
| Entrada Therapeutics | 183 |
| Puma Biotechnology | 172 |
| X4 Pharmaceuticals | 143 |
| Aura Biosciences | 109 |
| Neumora Therapeutics | 95 |
AVXL News
- 5 days ago - Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 - GlobeNewsWire
- 24 days ago - Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease - GlobeNewsWire
- 4 weeks ago - Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology - GlobeNewsWire
- 4 weeks ago - Anavex Life Sciences Receives FDA Feedback on Alzheimer's Disease Program - GlobeNewsWire
- 6 weeks ago - AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 7 weeks ago - Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion - GlobeNewsWire
- 2 months ago - Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease - GlobeNewsWire